Stock Index Research:
D.J. US Pharmaceutical (DJSPHM)
Stock index research analysis on stock value, growth and safety with the purely fact based Obermatt Method for Dow Jones U.S. Pharmaceuticals Index (DJSPHM, USA) from June 27, 2024.
D.J. US Pharmaceutical Research in Summary
Latest Research Results:
| Value Rank | 52 |  |
| Growth Rank | 52 | |
| Safety Rank | 49 |  |
| Combined Rank | 50 | |
| Country | USA |
| Analyzed | 26 Aktien |
| Sizes | Small bis XX-Large |
June 27, 2024. Index research is updated yearly. (Get Obermatt Stock Update)
D.J. US Pharmaceutical - Top 10 Stocks
Research History
The Obermatt stock index analysis shows how well the stocks in the D.J. US Pharmaceutical rank in respect to Obermatt's investment strategies. The higher the rank, the better the index fits the profile of that investment strategy. The result is weighted by the size of each stock in the entire Index. Compare other Indices: Index Research of all stock markets.
| STOCK INDEX RESEARCH | 2020 | 2021 | 2022 | 2023 | ||||
|---|---|---|---|---|---|---|---|---|
| INDEX VALUE RANKS | ||||||||
| INDEX VALUE RANKS | 25 |
|
28 |
|
65 |
|
52 |
|
| INDEX GROWTH RANKS | ||||||||
| INDEX GROWTH RANKS | 59 |
|
76 |
|
50 |
|
52 |
|
| INDEX SAFETY RANKS | ||||||||
| INDEX SAFETY RANKS | 36 |
|
37 |
|
54 |
|
49 |
|
| INDEX COMBINED RANKS | ||||||||
| INDEX COMBINED RANKS | 28 |
|
46 |
|
63 |
|
50 |
|